News
Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.
2604, 2023
Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth Initiatives
TA’s investment supports Diatech’s expansion of precision medicine diagnostics [...]
2104, 2023
Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023
Diatech Pharmacogenetics will join the Precision Med of Dubai, [...]
1411, 2022
1507, 2022
Diatech will attend the Jahrestagung Congress 7-10 October 2022, Vienna
The DGHO annual meeting in Vienna will bring together experts [...]
1104, 2022
1103, 2022
IVDR CERTIFICATION: WE GOT IT!
Diatech Pharmacogenetics is proud to announce the certification of [...]
2112, 2021
Happy Holidays 2021!
Our offices will be closed on [...]
712, 2021
We are pleased to report that the Easy Sars COV-2 Kit code RT020-WE can detect the new viral variant defined as Omicron
The primers and probes used in the current kit are [...]